Literature DB >> 23301369

WHO/INRUD drug prescribing indicators at primary health care centres in Eastern province, Saudi Arabia.

A A El Mahalli1.   

Abstract

Appropriate use of drugs is an essential element in achieving quality of health and medical care for patients and the community as a whole. This study aimed to measure the drug prescribing performance of primary health care centres in Eastern province, Saudi Arabia, using the WHO/International Network of Rational Use of Drugs core drug prescribing indicators. In a retrospective cohort study 10 health centres were selected using systematic random sampling. A total of 1000 prescribing encounters were investigated from January to December 2010. Mean values were: number of drugs per encounter 2.4 (optimal < or = 3), drugs prescribed by generic name 61.2% (optimal 100%), encounters with antibiotic prescribed 32.2% (optimal < or = 30%), encounters with injection prescribed 2% (optimal < or = 10%) and drugs prescribed from the national essential drugs list or facility formulary 99.2% (optimal 100%). An overall index of rational drug prescribing was calculated and applied to rank the health centres for benchmarking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23301369     DOI: 10.26719/2012.18.11.1091

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  26 in total

1.  Prescription practices & use of essential medicines in the primary health care system, Shimoga district, Karnataka, India.

Authors:  Gudadappa S Kasabi; Thilakavathi Subramanian; Ramesh Reddy Allam; Chitra A Grace; Shivanna Reddy; Manoj V Murhekar
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

2.  Challenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study.

Authors:  Paul G Ashigbie; Devine Azameti; Veronika J Wirtz
Journal:  J Pharm Policy Pract       Date:  2016-02-24

3.  General Practitioners' Prescribing Patterns at Primary Healthcare Centers in National Health Insurance, Gezira, Sudan.

Authors:  Bashir Mohamed Elmahi Yousif; Siripen Supakankunti
Journal:  Drugs Real World Outcomes       Date:  2016-09

4.  Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan.

Authors:  Muhammad Atif; Muhammad Rehan Sarwar; Muhammad Azeem; Mubeen Naz; Salma Amir; Kashaf Nazir
Journal:  BMC Health Serv Res       Date:  2016-12-08       Impact factor: 2.655

5.  Prescribing patterns of rural family physicians: a study in Kermanshah Province, Iran.

Authors:  Fariba Ahmadi; Ehsan Zarei
Journal:  BMC Public Health       Date:  2017-11-28       Impact factor: 3.295

6.  Retrospective Assessment of Antibiotics Prescribing at Public Primary Healthcare Facilities in Addis Ababa, Ethiopia.

Authors:  Fikru Worku; Dagmawit Tewahido
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-02-28

7.  Examination of WHO/INRUD Core Drug Use Indicators at Public Primary Healthcare Centers in Kisii County, Kenya.

Authors:  Aggrey O Nyabuti; Faith A Okalebo; Eric M Guantai
Journal:  Adv Pharmacol Pharm Sci       Date:  2020-06-19

8.  Assessment of the Appropriateness of Ceftazidime Use in a Tertiary Teaching Hospital, Northern Ethiopia.

Authors:  Teklu Gebrehiwot Gebremichael; Hiluf Hindeya Gebreyesus; Alem Gebremariam
Journal:  Drug Healthc Patient Saf       Date:  2019-12-20

9.  Drug use pattern using WHO core drug use indicators in public health centers of Dessie, North-East Ethiopia.

Authors:  Teklehaimanot Fentie Wendie; Abdulmejid Ahmed; Solomon Ahmed Mohammed
Journal:  BMC Med Inform Decis Mak       Date:  2021-06-25       Impact factor: 2.796

10.  Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan.

Authors:  Muhammad Atif; Muhammad Rehan Sarwar; Muhammad Azeem; Danial Umer; Abdul Rauf; Arslan Rasool; Muhammad Ahsan; Shane Scahill
Journal:  J Pharm Policy Pract       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.